ID   GRK6_HUMAN              Reviewed;         576 AA.
AC   P43250; O60541; Q13652;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   12-OCT-2022, entry version 208.
DE   RecName: Full=G protein-coupled receptor kinase 6;
DE            EC=2.7.11.16;
DE   AltName: Full=G protein-coupled receptor kinase GRK6;
GN   Name=GRK6; Synonyms=GPRK6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GRK6A).
RX   PubMed=8366096; DOI=10.1016/s0021-9258(19)36546-9;
RA   Benovic J.L., Gomez J.;
RT   "Molecular cloning and expression of GRK6. A new member of the G protein-
RT   coupled receptor kinase family.";
RL   J. Biol. Chem. 268:19521-19527(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS GRK6B AND GRK6C).
RX   PubMed=10506199; DOI=10.1074/jbc.274.41.29381;
RA   Premont R.T., Macrae A.D., Aparicio S.A., Kendall H.E., Welch J.E.,
RA   Lefkowitz R.J.;
RT   "The GRK4 subfamily of G protein-coupled receptor kinases. Alternative
RT   splicing, gene organization, and sequence conservation.";
RL   J. Biol. Chem. 274:29381-29389(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GRK6A).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 33-576, AND TISSUE SPECIFICITY.
RX   PubMed=8415712; DOI=10.1073/pnas.90.20.9398;
RA   Haribabu B., Snyderman R.;
RT   "Identification of additional members of human G-protein-coupled receptor
RT   kinase multigene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:9398-9402(1993).
RN   [6]
RP   PALMITOYLATION AT CYS-561; CYS-562 AND CYS-565, AND MUTAGENESIS OF CYS-561;
RP   CYS-562 AND CYS-565.
RX   PubMed=7961702; DOI=10.1016/s0021-9258(18)46852-4;
RA   Stoffel R.H., Randall R.R., Premont R.T., Lefkowitz R.J., Inglese J.;
RT   "Palmitoylation of G protein-coupled receptor kinase, GRK6. Lipid
RT   modification diversity in the GRK family.";
RL   J. Biol. Chem. 269:27791-27794(1994).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484 AND THR-485, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   FUNCTION IN PHOSPHORYLATION OF LRP6.
RX   PubMed=19801552; DOI=10.1074/jbc.m109.047456;
RA   Chen M., Philipp M., Wang J., Premont R.T., Garrison T.R., Caron M.G.,
RA   Lefkowitz R.J., Chen W.;
RT   "G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt
RT   pathway.";
RL   J. Biol. Chem. 284:35040-35048(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484 AND THR-485, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF CXCR4.
RX   PubMed=20048153; DOI=10.1074/jbc.m109.091173;
RA   Busillo J.M., Armando S., Sengupta R., Meucci O., Bouvier M., Benovic J.L.;
RT   "Site-specific phosphorylation of CXCR4 is dynamically regulated by
RT   multiple kinases and results in differential modulation of CXCR4
RT   signaling.";
RL   J. Biol. Chem. 285:7805-7817(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS).
RX   PubMed=16613860; DOI=10.1074/jbc.m601327200;
RA   Lodowski D.T., Tesmer V.M., Benovic J.L., Tesmer J.J.;
RT   "The structure of G protein-coupled receptor kinase (GRK)-6 defines a
RT   second lineage of GRKs.";
RL   J. Biol. Chem. 281:16785-16793(2006).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.72 ANGSTROMS) IN COMPLEX WITH AMP AND
RP   SANGIVAMYCIN, AND MUTAGENESIS OF ILE-6; VAL-7; ASN-9 AND LEU-12.
RX   PubMed=20729810; DOI=10.1038/emboj.2010.206;
RA   Boguth C.A., Singh P., Huang C.C., Tesmer J.J.;
RT   "Molecular basis for activation of G protein-coupled receptor kinases.";
RL   EMBO J. 29:3249-3259(2010).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-31; MET-73 AND MET-275.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Specifically phosphorylates the activated forms of G protein-
CC       coupled receptors. Such receptor phosphorylation initiates beta-
CC       arrestin-mediated receptor desensitization, internalization, and
CC       signaling events leading to their desensitization. Seems to be involved
CC       in the desensitization of D2-like dopamine receptors in striatum and
CC       chemokine receptor CXCR4 which is critical for CXCL12-induced cell
CC       chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro)
CC       and a non G-protein-coupled receptor: LRP6 during Wnt signaling (in
CC       vitro). {ECO:0000250, ECO:0000269|PubMed:19801552,
CC       ECO:0000269|PubMed:20048153}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[G-protein-coupled receptor] + ATP = [G-protein-coupled
CC         receptor]-phosphate + ADP + H(+); Xref=Rhea:RHEA:12008, Rhea:RHEA-
CC         COMP:11260, Rhea:RHEA-COMP:11261, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43176, ChEBI:CHEBI:68546,
CC         ChEBI:CHEBI:456216; EC=2.7.11.16;
CC   -!- SUBUNIT: Interacts with GIT1. {ECO:0000250|UniProtKB:P97711}.
CC   -!- INTERACTION:
CC       P43250; P05067: APP; NbExp=3; IntAct=EBI-722747, EBI-77613;
CC       P43250; P08238: HSP90AB1; NbExp=2; IntAct=EBI-722747, EBI-352572;
CC       P43250; P52205: ROM1; Xeno; NbExp=9; IntAct=EBI-722747, EBI-8176947;
CC       P43250-2; P05067: APP; NbExp=3; IntAct=EBI-6428342, EBI-77613;
CC   -!- SUBCELLULAR LOCATION: Membrane; Lipid-anchor.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=GRK6A;
CC         IsoId=P43250-1; Sequence=Displayed;
CC       Name=GRK6B;
CC         IsoId=P43250-2; Sequence=VSP_004938;
CC       Name=GRK6C;
CC         IsoId=P43250-3; Sequence=VSP_041813, VSP_041814;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:8415712}.
CC   -!- PTM: It is uncertain whether palmitoylation is on Cys-561 and/or Cys-
CC       562 and/or Cys-565. {ECO:0000269|PubMed:7961702}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. GPRK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L16862; AAA60175.1; -; mRNA.
DR   EMBL; AF040751; AAC09273.1; -; mRNA.
DR   EMBL; AF040752; AAC09274.1; -; mRNA.
DR   EMBL; AC145098; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009277; AAH09277.1; -; mRNA.
DR   EMBL; U00686; AAA03565.1; -; mRNA.
DR   CCDS; CCDS34303.1; -. [P43250-1]
DR   CCDS; CCDS43406.1; -. [P43250-3]
DR   PIR; A48765; A48765.
DR   RefSeq; NP_001004105.1; NM_001004105.2. [P43250-3]
DR   RefSeq; NP_001004106.1; NM_001004106.2. [P43250-1]
DR   RefSeq; NP_002073.2; NM_002082.3. [P43250-2]
DR   PDB; 2ACX; X-ray; 2.60 A; A/B=1-576.
DR   PDB; 3NYN; X-ray; 2.72 A; A/B=2-576.
DR   PDB; 3NYO; X-ray; 2.92 A; A/B=2-576.
DR   PDBsum; 2ACX; -.
DR   PDBsum; 3NYN; -.
DR   PDBsum; 3NYO; -.
DR   AlphaFoldDB; P43250; -.
DR   SMR; P43250; -.
DR   BioGRID; 109128; 56.
DR   IntAct; P43250; 102.
DR   MINT; P43250; -.
DR   STRING; 9606.ENSP00000433511; -.
DR   BindingDB; P43250; -.
DR   ChEMBL; CHEMBL6144; -.
DR   GuidetoPHARMACOLOGY; 1470; -.
DR   CarbonylDB; P43250; -.
DR   iPTMnet; P43250; -.
DR   PhosphoSitePlus; P43250; -.
DR   SwissPalm; P43250; -.
DR   BioMuta; GRK6; -.
DR   DMDM; 20141386; -.
DR   EPD; P43250; -.
DR   jPOST; P43250; -.
DR   MassIVE; P43250; -.
DR   MaxQB; P43250; -.
DR   PaxDb; P43250; -.
DR   PeptideAtlas; P43250; -.
DR   PRIDE; P43250; -.
DR   ProteomicsDB; 55602; -. [P43250-1]
DR   ProteomicsDB; 55603; -. [P43250-2]
DR   ProteomicsDB; 55604; -. [P43250-3]
DR   ABCD; P43250; 1 sequenced antibody.
DR   Antibodypedia; 17408; 402 antibodies from 36 providers.
DR   DNASU; 2870; -.
DR   Ensembl; ENST00000355472.10; ENSP00000347655.5; ENSG00000198055.11. [P43250-1]
DR   Ensembl; ENST00000355958.9; ENSP00000348230.5; ENSG00000198055.11. [P43250-3]
DR   Ensembl; ENST00000528793.5; ENSP00000433511.1; ENSG00000198055.11. [P43250-2]
DR   GeneID; 2870; -.
DR   KEGG; hsa:2870; -.
DR   MANE-Select; ENST00000355472.10; ENSP00000347655.5; NM_001004106.3; NP_001004106.1.
DR   UCSC; uc003mgq.3; human. [P43250-1]
DR   CTD; 2870; -.
DR   DisGeNET; 2870; -.
DR   GeneCards; GRK6; -.
DR   HGNC; HGNC:4545; GRK6.
DR   HPA; ENSG00000198055; Tissue enhanced (bone).
DR   MIM; 600869; gene.
DR   neXtProt; NX_P43250; -.
DR   OpenTargets; ENSG00000198055; -.
DR   PharmGKB; PA28942; -.
DR   VEuPathDB; HostDB:ENSG00000198055; -.
DR   eggNOG; KOG0986; Eukaryota.
DR   GeneTree; ENSGT00940000158544; -.
DR   InParanoid; P43250; -.
DR   OMA; TQCTERL; -.
DR   OrthoDB; 1104340at2759; -.
DR   PhylomeDB; P43250; -.
DR   TreeFam; TF313940; -.
DR   BRENDA; 2.7.11.16; 2681.
DR   PathwayCommons; P43250; -.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   SignaLink; P43250; -.
DR   SIGNOR; P43250; -.
DR   BioGRID-ORCS; 2870; 14 hits in 1110 CRISPR screens.
DR   ChiTaRS; GRK6; human.
DR   EvolutionaryTrace; P43250; -.
DR   GeneWiki; GRK6; -.
DR   GenomeRNAi; 2870; -.
DR   Pharos; P43250; Tchem.
DR   PRO; PR:P43250; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P43250; protein.
DR   Bgee; ENSG00000198055; Expressed in granulocyte and 201 other tissues.
DR   ExpressionAtlas; P43250; baseline and differential.
DR   Genevisible; P43250; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047696; F:beta-adrenergic receptor kinase activity; IDA:CACAO.
DR   GO; GO:0004703; F:G protein-coupled receptor kinase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0008277; P:regulation of G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0009966; P:regulation of signal transduction; IBA:GO_Central.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.167.10; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000239; GPCR_kinase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016137; RGS.
DR   InterPro; IPR036305; RGS_sf.
DR   InterPro; IPR044926; RGS_subdomain_2.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00615; RGS; 1.
DR   PRINTS; PR00717; GPCRKINASE.
DR   SMART; SM00315; RGS; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50132; RGS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase; Lipoprotein;
KW   Membrane; Nucleotide-binding; Palmitate; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Wnt signaling pathway.
FT   CHAIN           1..576
FT                   /note="G protein-coupled receptor kinase 6"
FT                   /id="PRO_0000085974"
FT   DOMAIN          53..171
FT                   /note="RGS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00171"
FT   DOMAIN          186..448
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          449..514
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   REGION          1..185
FT                   /note="N-terminal"
FT   ACT_SITE        311
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         192..200
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         215
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         264..270
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         315..318
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         485
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         566
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O70293"
FT   MOD_RES         568
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O70293"
FT   LIPID           561
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:7961702"
FT   LIPID           562
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:7961702"
FT   LIPID           565
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:7961702"
FT   VAR_SEQ         560..576
FT                   /note="DCCGNCSDSEEELPTRL -> RIAVETAATARKSSPPASSPQPEAPTSSWR
FT                   (in isoform GRK6B)"
FT                   /evidence="ECO:0000303|PubMed:10506199"
FT                   /id="VSP_004938"
FT   VAR_SEQ         560
FT                   /note="D -> R (in isoform GRK6C)"
FT                   /evidence="ECO:0000303|PubMed:10506199"
FT                   /id="VSP_041813"
FT   VAR_SEQ         561..576
FT                   /note="Missing (in isoform GRK6C)"
FT                   /evidence="ECO:0000303|PubMed:10506199"
FT                   /id="VSP_041814"
FT   VARIANT         31
FT                   /note="R -> Q (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs141014084)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040524"
FT   VARIANT         73
FT                   /note="T -> M (in dbSNP:rs56382815)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040525"
FT   VARIANT         275
FT                   /note="I -> M (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040526"
FT   MUTAGEN         6
FT                   /note="I->A: 12-13 fold defects in kinase activity;
FT                   180-fold defects in kinase activity; when associated with
FT                   A-7."
FT                   /evidence="ECO:0000269|PubMed:20729810"
FT   MUTAGEN         7
FT                   /note="V->A: 12-13 fold defects in kinase activity;
FT                   180-fold defects in kinase activity; when associated with
FT                   A-6."
FT                   /evidence="ECO:0000269|PubMed:20729810"
FT   MUTAGEN         9
FT                   /note="N->A: 140-fold defects in kinase activity."
FT                   /evidence="ECO:0000269|PubMed:20729810"
FT   MUTAGEN         12
FT                   /note="L->A: 1100-fold defects in kinase activity."
FT                   /evidence="ECO:0000269|PubMed:20729810"
FT   MUTAGEN         561
FT                   /note="C->S: Abolishes palmitoylation; when associated with
FT                   S-562 and S-565."
FT                   /evidence="ECO:0000269|PubMed:7961702"
FT   MUTAGEN         562
FT                   /note="C->S: Abolishes palmitoylation; when associated with
FT                   S-561 and S-565."
FT                   /evidence="ECO:0000269|PubMed:7961702"
FT   MUTAGEN         565
FT                   /note="C->S: Abolishes palmitoylation; when associated with
FT                   S-561 and S-562."
FT                   /evidence="ECO:0000269|PubMed:7961702"
FT   CONFLICT        60..61
FT                   /note="QP -> HA (in Ref. 1; AAA60175)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        104..105
FT                   /note="QL -> HV (in Ref. 1; AAA60175)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..18
FT                   /evidence="ECO:0007829|PDB:3NYN"
FT   STRAND          23..25
FT                   /evidence="ECO:0007829|PDB:3NYN"
FT   HELIX           30..33
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           43..48
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           53..57
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           61..71
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           75..91
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   TURN            95..97
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           98..109
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          112..114
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          117..120
FT                   /evidence="ECO:0007829|PDB:3NYN"
FT   HELIX           123..135
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   TURN            139..142
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           143..153
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           156..162
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           165..177
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           183..185
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          186..195
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          198..205
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   TURN            206..208
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          211..218
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           219..224
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           228..240
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          249..254
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          256..263
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           271..276
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          277..280
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           285..304
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           314..316
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          317..319
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          325..327
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           349..351
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           354..357
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          361..364
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           365..380
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          384..386
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          388..390
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           394..403
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          410..412
FT                   /evidence="ECO:0007829|PDB:3NYN"
FT   HELIX           414..423
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           428..430
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          435..437
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           438..443
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           446..448
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           453..457
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           477..479
FT                   /evidence="ECO:0007829|PDB:3NYO"
FT   HELIX           493..502
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           508..517
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           520..525
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   STRAND          527..530
FT                   /evidence="ECO:0007829|PDB:2ACX"
FT   HELIX           549..555
FT                   /evidence="ECO:0007829|PDB:3NYN"
SQ   SEQUENCE   576 AA;  65991 MW;  3BF8C3B1CDE2BD74 CRC64;
     MELENIVANT VLLKAREGGG GNRKGKSKKW RQMLQFPHIS QCEELRLSLE RDYHSLCERQ
     PIGRLLFREF CATRPELSRC VAFLDGVAEY EVTPDDKRKA CGRQLTQNFL SHTGPDLIPE
     VPRQLVTNCT QRLEQGPCKD LFQELTRLTH EYLSVAPFAD YLDSIYFNRF LQWKWLERQP
     VTKNTFRQYR VLGKGGFGEV CACQVRATGK MYACKKLEKK RIKKRKGEAM ALNEKQILEK
     VNSRFVVSLA YAYETKDALC LVLTLMNGGD LKFHIYHMGQ AGFPEARAVF YAAEICCGLE
     DLHRERIVYR DLKPENILLD DHGHIRISDL GLAVHVPEGQ TIKGRVGTVG YMAPEVVKNE
     RYTFSPDWWA LGCLLYEMIA GQSPFQQRKK KIKREEVERL VKEVPEEYSE RFSPQARSLC
     SQLLCKDPAE RLGCRGGSAR EVKEHPLFKK LNFKRLGAGM LEPPFKPDPQ AIYCKDVLDI
     EQFSTVKGVE LEPTDQDFYQ KFATGSVPIP WQNEMVETEC FQELNVFGLD GSVPPDLDWK
     GQPPAPPKKG LLQRLFSRQD CCGNCSDSEE ELPTRL
//
